$0.72
2.70% today
Nasdaq, Feb 28, 09:49 pm CET
ISIN
US75120L1008
Symbol
RLYB

Rallybio Corp Target price 2025 - Analyst rating & recommendation

Rallybio Corp Classifications & Recommendation:

Buy
100%

Rallybio Corp Price Target

Target Price $8.25
Price $0.74
Potential
Number of Estimates 4
4 Analysts have issued a price target Rallybio Corp 2026 . The average Rallybio Corp target price is $8.25. This is higher than the current stock price. The highest price target is
$13.00 1,656.76%
register free of charge
, the lowest is .
A rating was issued by 5 analysts: 5 Analysts recommend Rallybio Corp to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Rallybio Corp stock has an average upside potential 2026 of . Most analysts recommend the Rallybio Corp stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 0.00 0.67

4 Analysts have issued a sales forecast Rallybio Corp 2024 . The average Rallybio Corp sales estimate is

$674k
Unlock
. This is
12.30% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$897k 49.50%
Unlock
, the lowest is
$598k 0.33%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $0.0
2025
$305k 54.73%
Unlock
2026
$0.0 100.00%
Unlock
2028
$388m 341.52%
Unlock

1 Analyst has issued a net profit forecast Rallybio Corp 2024 . The average Rallybio Corp net profit estimate is

$-54.8m
Unlock
. This is
16.98% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-54.8m 16.98%
Unlock
, the lowest is
$-54.8m 16.98%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-76.3m 11.96%
2024
$-54.8m 28.26%
Unlock
2025
$-39.4m 28.03%
Unlock
2026
$-44.4m 12.61%
Unlock
2027
$7.9m 117.75%
Unlock
2028
$193m 2,343.02%
Unlock

Net Margin

2025
-12,923.11% 58.98%
Unlock
2028
49.60% 452.95%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -1.84 -1.32
11.96% 28.26%
P/E negative
EV/Sales negative

1 Analysts have issued a Rallybio Corp forecast for earnings per share. The average Rallybio Corp <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-1.32
Unlock
. This is
16.98% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-1.32 16.98%
Unlock
, the lowest is
$-1.32 16.98%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-1.84 11.96%
2024
$-1.32 28.26%
Unlock
2025
$-0.95 28.03%
Unlock
2026
$-1.07 12.63%
Unlock
2027
$0.19 117.76%
Unlock
2028
$4.64 2,342.11%
Unlock

P/E ratio

Current -0.47 50.00%
2024
-0.56 19.15%
Unlock
2025
-0.78 39.29%
Unlock
2026
-0.69 11.54%
Unlock
2027
3.89 663.77%
Unlock
2028
0.16 95.89%
Unlock

Based on analysts' sales estimates for 2024, the Rallybio Corp stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

-65.62
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
45.57
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -73.68
2024
-65.62 10.94%
Unlock
2025
-144.95 120.90%
Unlock
2028
-0.11 77.36%
Unlock

P/S ratio

Current
2024
45.57 10.95%
Unlock
2025
100.66 120.90%
Unlock
2028
0.08 77.35%
Unlock

Current Rallybio Corp Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co. Locked ➜ Locked Locked Feb 12 2025
HC Wainwright & Co. Locked ➜ Locked Locked Jan 13 2025
HC Wainwright & Co. Locked ➜ Locked Locked Dec 03 2024
HC Wainwright & Co. Locked ➜ Locked Locked Nov 22 2024
HC Wainwright & Co. Locked ➜ Locked Locked Nov 08 2024
HC Wainwright & Co. Locked ➜ Locked Locked Oct 30 2024
HC Wainwright & Co. Locked ➜ Locked Locked Oct 01 2024
Analyst Rating Date
Locked
HC Wainwright & Co.: Locked ➜ Locked
Feb 12 2025
Locked
HC Wainwright & Co.: Locked ➜ Locked
Jan 13 2025
Locked
HC Wainwright & Co.: Locked ➜ Locked
Dec 03 2024
Locked
HC Wainwright & Co.: Locked ➜ Locked
Nov 22 2024
Locked
HC Wainwright & Co.: Locked ➜ Locked
Nov 08 2024
Locked
HC Wainwright & Co.: Locked ➜ Locked
Oct 30 2024
Locked
HC Wainwright & Co.: Locked ➜ Locked
Oct 01 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today